Fennec Pharmaceuticals (FENC) Exchange Rate Effect (2011)
Fennec Pharmaceuticals (FENC) posted Exchange Rate Effect of -$110000.0 for Q4 2011, down 478.95% on a QoQ basis from -$19000.0 in Q3 2011.
Fennec Pharmaceuticals (FENC) Exchange Rate Effect (2011) Analysis & Trends
Fennec Pharmaceuticals' Exchange Rate Effect history runs 1 years deep, the most recent figure standing at -$110000.0 for Q4 2011.
- Quarterly Exchange Rate Effect changed N/A year-over-year to -$110000.0 in Q4 2011, while the trailing twelve-month figure through Sep 2012 was -$110000.0 (changed N/A YoY) and the FY2011 annual result came in at $10000.0, changed N/A from the prior year.
- Exchange Rate Effect was -$110000.0 for Q4 2011 at Fennec Pharmaceuticals, down from -$19000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $124000.0 in Q1 2011 and bottomed at -$110000.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Fennec Pharmaceuticals | 287.77 Mn | 250.98 Mn | 12.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | -110,000.00 |
| Dec 31, 2011 | -110,000.00 |
| Sep 30, 2011 | -19,000.00 |
| Sep 30, 2011 | -19,000.00 |
| Jun 30, 2011 | 15,000.00 |
| Jun 30, 2011 | 15,000.00 |
| Mar 31, 2011 | 124,000.00 |
| Mar 31, 2011 | 124,000.00 |